Cerus Corp: Enhancing the Safety of Blood

The INTERCEPT Blood System is an innovation based on the proprietary technology of Cerus Corporation, a biomedical products company that is headquartered in Concord, California. The company has operations in Europe, in the Middle East and in the Commonwealth of Independent States.

The mission of the company is to enhance the safety of blood. Through its technology, they are able to control the biological replication and inactivation of blood-borne pathogens. This process filters and eliminates the presence of bacteria, parasites and viruses in blood while maintaining and preserving the therapeutic components of plasma, red blood cells and platelets. This system is most useful, especially during blood transfusion. Their INTERCEPT red blood cell system is one of their products that is currently in its clinical development phase.

Cerus Corporation partners with other biopharmaceutical companies like Baxter International to enhance and hasten the process of development some of its novel products. The company markets its platelet and plasma systems through their distributors and direct sales force around the globe.